IDH2 and acute myeloid leukemia: It decreased the level of intracellular and extracellular 2-HG in a dose- and time-dependent manner and induced differentiation of IDH2-mut TF-1 human erythroleukemia cells in vitro and primary human AML cells cultured ex vivo [80].